Claude discovers new enzyme system: What's behind the ART sequence

TVS News AI, editorially supervised, presents Claude discovers new enzyme system: What's behind the ART sequence.

When an AI suddenly does biology, it sounds like science fiction at first. But that's exactly what Anthropic, the developer behind the language model Claude, is now claiming: In its in-house biotech lab, the AI discovered a previously unknown enzyme system – named after the sequence "ART". You're wondering what's behind it and whether it's really as big as it sounds? We summarize what's known so far.

According to Anthropic, Claude searched publicly accessible DNA databases and came across a gene sequence that had not been catalogued before. The previously unknown sequence is referred to as "ART" and is said to – according to the company's account – show similarities to CRISPR, the well-known tool for targeted genome editing.

Heise online and t3n report consistently on this announcement. According to both sources, this is the first published discovery from Anthropic's new biotech lab, which according to t3n was founded in the spring of this year. What the discovery means scientifically in concrete terms and how it has been independently reviewed cannot be determined from the available sources.

What is ART – and why does it remind us of CRISPR?

CRISPR has revolutionized genetic engineering in recent years because it allows researchers to cut and modify DNA in a targeted way. If ART allegedly shows "similarities" to CRISPR according to Anthropic, this could indicate that a novel mechanism for genome editing has been found here as well – or at least a biological element that works in a similar direction. However, both available sources formulate the similarity as a claim by the company, not as a finding confirmed by independent parties.

How should this announcement be interpreted?

Important for you: Both t3n and Heise online base their reports essentially on the announcement from Anthropic itself. An independent scientific publication, a peer review, or confirmation by external research teams is not mentioned in the available sources. "Allegedly discovered" – that's how both headlines deliberately phrase it cautiously. This is not distrust, but a hint: as long as no independent review is available, the classification remains preliminary.

Anthropic's biotech lab: The context

The fact that an AI company operates its own biotech lab at all is remarkable. According to t3n, the lab was founded in the spring; the ART announcement is the first concrete discovery to come from it. This positions Anthropic in a field where AI models have already been used for analyzing biological data for some time – but the announcement goes a step further: here, an AI is said to have independently identified something new that human researchers had previously missed.

What needs to happen next for the announcement to become a robust scientific finding: external replication, publication of the methodology, and traceable data. Until then: exciting, but to be read with the appropriate caution.